Counterpoint Mutual Funds’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,479
Closed -$288K – 395
2026
Q2
$288K Sell
10,479
-102,542
-91% -$3.37M 0.03% 262
2026
Q1
$4.21M Buy
+113,021
New +$4.66M 0.63% 46
2025
Q2
– Sell
-26,547
Closed -$1.34M – 363
2025
Q1
$1.34M Buy
+26,547
New +$1.32M 0.19% 45
2023
Q2
– Sell
-2,301
Closed -$106K – 374
2023
Q1
$106K Sell
2,301
-552
-19% -$25.8K 0.09% 217
2022
Q4
$132K Buy
+2,853
New +$130K 0.14% 173
2021
Q3
– Sell
-291
Closed -$13K – 192
2021
Q2
$13K Buy
+291
New +$13.2K 0.01% 70

Other funds holding G

Counterpoint Mutual Funds's G Position: Q3 2026 in Review

Counterpoint Mutual Funds sold out of Genpact (G) in Q3 2026, closing a stake of 10,479 shares — an estimated $288K sold.

Counterpoint Mutual Funds first reported a position in G in Q2 2021 and held it in 6 quarters. The position peaked at $4.21M in Q1 2026. 123 funds tracked by Wall St. Rank hold G as of Q3 2026.

  • Counterpoint Mutual Funds reported no remaining Genpact position as of Q3 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 10,479 Genpact shares in Q3 2026, an estimated $288K.
  • Counterpoint Mutual Funds first reported a position in Genpact in Q2 2021 and held it in 6 quarters.
  • Counterpoint Mutual Funds's Genpact position peaked at $4.21M in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Genpact as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.